Validation of the P21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2

Cancer Research - United States
doi 10.1158/0008-5472.can-08-0866
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

P21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2

PLoS ONE
Multidisciplinary
2010English

Pseudosubstrate Regulation of the Type II P21-Activated Kinases (PAKs)

Biophysical Journal
Biophysics
2013English

Neurofibromatosis Type 2

Neurology
Neurology
2007English

Inhibition of Group 1 P21-Activated Kinases Suppresses Pancreatic Stellate Cell Activation and Increases Survival of Mice With Pancreatic Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Group I P21-Activated Kinases: Emerging Roles in Immune Function and Viral Pathogenesis

International Journal of Biochemistry and Cell Biology
BiochemistryCell Biology
2010English

Expression of P21-Activated Kinases 1 and 3 Is Altered in the Brain of Subjects With Depression

Neuroscience
Neuroscience
2016English

Inhibition or Ablation of P21-Activated Kinase (PAK1) Disrupts Glucose Homeostatic Mechanismsin Vivo

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Inhibition of P21-Activated Kinase 4 Expression Suppresses the Proliferation of Hep-2 Laryngeal Carcinoma Cells via Activation of the ATM/Chk1/2/p53 Pathway

International Journal of Oncology
Cancer ResearchOncology
2012English

Mitogen-Activated Protein Kinases as Glucose Transducers for Diabetic Complications

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy